Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Calomel, or mercury(I) chloride, is a chemical allergen used primarily in diagnostic patch testing to identify mercury sensitivities. It belongs to the class of Non-Standardized Food Allergenic Extracts and Standardized Chemical Allergens.
Name
Calomel
Raw Name
CALOMEL
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
11
Variant Count
22
Last Verified
February 17, 2026
About Calomel
Calomel, or mercury(I) chloride, is a chemical allergen used primarily in diagnostic patch testing to identify mercury sensitivities. It belongs to the class of Non-Standardized Food Allergenic Extracts and Standardized Chemical Allergens.
Detailed information about Calomel
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Calomel.
Today, Calomel serves a specialized diagnostic role. It is primarily utilized in patch testing—a method used by dermatologists and allergists to determine if a patient has a delayed-type hypersensitivity (Type IV) reaction to mercury or mercury-containing compounds. When used as an allergenic extract, it is typically prepared in a petrolatum base at a specific concentration (often 0.5% to 1.0%). This allows clinicians to identify contact dermatitis triggers in patients who may be exposed to mercury in dental amalgams, industrial settings, or certain environmental sources.
Calomel belongs to the pharmacological class of Standardized Chemical Allergens. Its history is one of the most storied in pharmacology; it was famously used by Dr. Benjamin Rush during the 1793 yellow fever epidemic and was a staple in the medical kits of the Lewis and Clark expedition. However, as the understanding of heavy metal toxicity evolved, the FDA and other global health authorities phased out Calomel for internal consumption. It is now strictly regulated as a diagnostic tool or a laboratory chemical.
As a diagnostic allergen, Calomel works by inducing a localized, controlled immune response. When applied to the skin of a sensitized individual, the mercurous ions ($Hg_2^{2+}$) act as haptens. A hapten is a small molecule that, by itself, cannot elicit an immune response but becomes antigenic when it binds to larger proteins (carrier proteins) within the skin's epidermis.
Once the Calomel-protein complex is formed, it is taken up by Langerhans cells (specialized antigen-presenting cells in the skin). These cells process the complex and migrate to local lymph nodes, where they present the antigen to T-lymphocytes. In individuals previously sensitized to mercury, this triggers the activation and proliferation of memory T-cells. These T-cells then migrate back to the site of application, releasing pro-inflammatory cytokines such as interferon-gamma and tumor necrosis factor-alpha. This molecular cascade results in the clinical manifestation of a positive patch test: localized erythema (redness), edema (swelling), and sometimes vesiculation (blistering). This process typically takes 48 to 96 hours to manifest, which is why patch test readings are delayed.
At the molecular level, the toxicity of Calomel (if ingested or absorbed systemically) is due to the affinity of mercury ions for sulfhydryl (-SH) groups on enzymes and structural proteins. This binding inhibits essential cellular functions, leading to oxidative stress, disruption of the blood-brain barrier, and renal tubular necrosis.
Because Calomel is currently used primarily as a topical diagnostic agent, its systemic pharmacokinetic profile is characterized by minimal absorption under normal conditions. However, understanding its behavior is crucial for safety.
Calomel is currently indicated for the following:
Calomel is not available as a standard prescription medication for patient administration. It is found in:
> Important: Only your healthcare provider can determine if Calomel is right for your specific diagnostic needs. It should never be ingested or applied to large areas of the body.
For diagnostic purposes, the dosage of Calomel is not measured in milligrams per kilogram of body weight, but rather in the concentration of the allergen applied to the skin.
Calomel is generally not recommended for use in children unless the clinical suspicion of mercury allergy is high and other diagnostic avenues have been exhausted.
Because Calomel is applied topically in minute quantities for diagnostic testing, dosage adjustments are typically not required for patients with renal impairment. However, if a patient has severe, end-stage renal disease, clinicians should monitor the test site closely for any signs of hyper-absorption, as the kidneys are the primary route for mercury excretion.
No dosage adjustments are defined for hepatic impairment in the context of patch testing. The liver's role in the clearance of inorganic mercury is secondary to the kidneys.
Elderly patients often have thinner skin (atrophy), which may increase the rate of percutaneous absorption. While the standard 0.5-1.0% concentration is used, the healthcare provider may exercise caution and monitor for localized skin breakdown.
Calomel is NEVER to be taken by the patient. It must be administered by a trained healthcare professional (typically an allergist or dermatologist).
In the context of diagnostic testing, a "missed dose" refers to a patch that has fallen off or become wet. If the patch is removed before the 48-hour mark, the test is considered invalid. You should contact your doctor to reschedule the test. Do not attempt to re-apply the patch yourself using household adhesives.
Systemic overdose from a single diagnostic patch test is extremely unlikely. However, historical systemic overdose (ingestion) or accidental industrial exposure leads to Mercurialism.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to perform skin tests at home without medical guidance.
Because Calomel is used to provoke an allergic reaction in sensitized individuals, the "side effects" at the application site are often the intended diagnostic markers. Common reactions include:
While extremely rare with diagnostic patch testing, systemic reactions can occur.
> Warning: Stop taking Calomel (or alert your doctor during testing) and call your doctor immediately if you experience any of these:
Long-term side effects are generally not associated with a single diagnostic application of Calomel. However, chronic exposure to Calomel (historically or industrially) can lead to:
There are no specific FDA Black Box Warnings for Calomel when used as a Standardized Chemical Allergen. However, the FDA has issued general warnings regarding mercury-containing products, emphasizing that mercury is a potent neurotoxin and nephrotoxin. The use of mercury in drugs has been largely prohibited under 21 CFR 310.530, except in very specific cases like allergenic extracts where no suitable alternative exists.
Report any unusual symptoms to your healthcare provider. If you notice symptoms like tremors, metallic taste, or changes in urinary output following a patch test, inform your specialist immediately.
Calomel (mercurous chloride) is a heavy metal compound. Its use is strictly limited to diagnostic applications under the supervision of a medical professional. It should never be used as a self-treatment for any condition. The primary risk associated with Calomel is mercury poisoning, which can occur through ingestion, inhalation of dust, or excessive skin absorption.
No FDA black box warnings for Calomel as an allergenic extract. However, historical data and toxicological profiles for mercury compounds suggest extreme caution. The FDA's 1998 ruling on mercury-containing over-the-counter (OTC) products effectively banned Calomel from general consumer use due to its lack of safety and efficacy as a therapeutic agent.
If systemic exposure is suspected (e.g., accidental ingestion or industrial spill), the following monitoring is required:
Standard diagnostic patch testing with Calomel does not typically interfere with the ability to drive or operate machinery. However, if a patient experiences a significant systemic reaction or severe discomfort from the patch, they should exercise caution.
There are no known direct interactions between topical Calomel patch testing and alcohol. However, alcohol can cause vasodilation (widening of blood vessels), which might increase skin sensitivity or itching at the test site.
In the context of patch testing, "discontinuation" means removing the patch. If severe burning, pain, or systemic symptoms occur before the 48-hour mark, the patch should be removed immediately, and the area should be washed thoroughly with soap and water.
> Important: Discuss all your medical conditions with your healthcare provider before starting Calomel testing.
For each major interaction, the mechanism is typically pharmacodynamic (altering the immune response) rather than pharmacokinetic (altering drug metabolism). The management strategy is usually to delay testing until the interfering substance has cleared the system.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Calomel must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are sensitive to Calomel may also react to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Calomel.
Calomel is classified as Pregnancy Category X (if used systemically) and should be avoided in diagnostic patch testing during pregnancy. Mercury is a potent neurotoxin that readily crosses the placenta. Exposure during the first trimester can lead to significant developmental abnormalities, including microcephaly, blindness, and severe motor impairment (similar to Minamata disease). Even low-level exposure during the third trimester can affect fetal brain development and cognitive function. If a mercury allergy is suspected during pregnancy, testing should be deferred until after delivery.
Inorganic mercury can be excreted in breast milk, although the amount absorbed from a small diagnostic patch is likely negligible. However, because of the high sensitivity of the infant's developing nervous system, healthcare providers typically recommend delaying Calomel patch testing until the mother has finished breastfeeding.
Calomel is not FDA-approved for standard use in the pediatric population. Children are particularly susceptible to mercury toxicity, which can manifest as Acrodynia. This condition is characterized by painful, pink, swollen hands and feet, irritability, and insomnia. If patch testing is absolutely necessary, it must be done with extreme caution, using the lowest possible concentration and the shortest exposure time.
In elderly patients, the skin is often thinner and more permeable, which may increase the risk of localized irritation or systemic absorption. Additionally, elderly patients are more likely to have reduced renal function (lower GFR), which could slow the clearance of any absorbed mercury. Clinicians should use the standard 0.5% concentration but monitor the site closely for skin breakdown.
Patients with a GFR below 30 mL/min should be approached with caution. While topical absorption is low, any mercury that does enter the bloodstream will be harder for the body to eliminate. There are no specific GFR-based dose adjustments for patch testing, but systemic monitoring should be considered if an unusually large area of skin is exposed.
No specific adjustments are required for patients with liver disease, as the liver is not the primary organ for the metabolism or excretion of mercurous chloride.
> Important: Special populations require individualized medical assessment.
Calomel (mercurous chloride) acts as a haptenic allergen. Because the mercurous ion ($Hg_2^{2+}$) is too small to be recognized by the immune system on its own, it must bind covalently to endogenous proteins in the skin. This mercury-protein complex is then recognized as "foreign" by the immune system.
In the context of historical systemic use, Calomel acted as an irritant to the intestinal mucosa. Because of its low solubility, it stayed in the gut and caused a vigorous secretagogue effect, leading to the rapid evacuation of the bowels. However, some of this was converted to mercuric chloride, which then inhibited the sodium-potassium ATPase pump in the renal tubules, leading to the characteristic diuresis and subsequent nephrotoxicity associated with historical use.
| Parameter | Value |
|---|---|
| Bioavailability | < 1% (Intact Skin) |
| Protein Binding | > 99% (primarily Albumin) |
| Half-life | 30 - 60 Days (Systemic) |
| Tmax | 48 - 72 hours (Local response) |
| Metabolism | Non-enzymatic (Oxidation/Reduction) |
| Excretion | Renal (80%), Fecal (20%) |
Calomel is classified as a Standardized Chemical Allergen and a Non-Standardized Food Allergenic Extract. It is grouped with other heavy metal allergens such as Nickel Sulfate, Cobalt Chloride, and Potassium Dichromate.
Medications containing this ingredient
Common questions about Calomel
In modern medicine, Calomel is used exclusively as a diagnostic tool for allergy testing, specifically in a procedure called patch testing. It helps dermatologists determine if a patient has a delayed-type allergic reaction to mercury, which can be found in dental fillings or industrial environments. It is no longer used as a medication to be swallowed or applied for therapeutic purposes due to its high toxicity. If your doctor mentions Calomel, they are likely referring to a skin test to investigate contact dermatitis. Always follow the specific instructions provided by your allergy specialist during the testing period.
The most common side effects of Calomel when used in a patch test are localized skin reactions at the site of application. These include redness, itching, and sometimes small blisters if you are allergic to the substance. These symptoms are actually the 'positive' signs the doctor is looking for to confirm an allergy. Most of these local reactions fade within a few days to a week after the patch is removed. However, if you experience a rash that spreads across your whole body or have trouble breathing, you must seek emergency medical care immediately. Always report any severe discomfort to your healthcare provider during the test.
While there is no direct chemical interaction between alcohol and the small amount of Calomel used in a patch test, it is generally advised to avoid excessive alcohol consumption during the 48 to 96 hours of testing. Alcohol can cause your blood vessels to dilate and may increase skin itching or sensitivity, which could interfere with the accuracy of the test results. Furthermore, alcohol can increase sweating, which might cause the diagnostic patches to fall off or the allergen to leak out of its chamber. For the most accurate results, maintain your normal routine but avoid anything that might irritate your skin or cause excessive perspiration. Discuss your lifestyle habits with your doctor before starting the test.
Calomel is generally considered unsafe during pregnancy and should be avoided for diagnostic testing. Mercury, the primary component of Calomel, is a known neurotoxin that can cross the placenta and harm the developing fetus's brain and nervous system. Even though the amount used in a patch test is very small, the potential risks to the baby usually outweigh the benefits of the diagnosis. If you are pregnant or planning to become pregnant, inform your doctor immediately so they can postpone the test until after delivery. Protecting the health of the developing fetus is the priority in these clinical situations.
As a diagnostic allergen, Calomel works through a delayed-type hypersensitivity reaction, which takes time to manifest. You will typically have the patch applied to your back for 48 hours, during which time your immune system 'processes' the allergen. The first reading is usually done when the patch is removed at the 48-hour mark, but a final reading is often required at 72 or 96 hours. This is because some allergic reactions to metals like mercury are slow to develop and may not be visible on the second day. It is crucial to attend all follow-up appointments to ensure the doctor gets an accurate reading of the test.
Since Calomel is not a medication you take daily, but rather a one-time diagnostic application, 'stopping' it simply means having the patch removed by your doctor. You should not remove the patch yourself unless you experience a severe, painful reaction or signs of an emergency. Removing the patch early will invalidate the test results and may require you to start the process over again. If the test site becomes unbearably itchy or painful, call your doctor's office for advice before taking any action. Once the test is complete and the patch is removed, there is no withdrawal period or need to taper off.
In the context of Calomel patch testing, a 'missed dose' occurs if the patch falls off or gets wet before the 48-hour reading. If this happens, you should not try to tape it back on yourself or apply any other substance to the area. Instead, contact your dermatologist or allergist's office immediately to inform them. They will decide if the test can still be read or if it needs to be rescheduled for a later date. To prevent this, avoid showering the area, sweating heavily, or wearing tight clothing that might rub against the patches during the testing period.
There is no evidence that the diagnostic use of Calomel in patch testing causes weight gain. The amount of the substance used is extremely small and is applied only to a tiny area of the skin for a short period. Weight gain is typically associated with systemic medications that affect metabolism, hormones, or appetite, which Calomel does not do in its diagnostic form. If you notice sudden weight gain or swelling (edema) in your legs after a test, you should contact your doctor, as this could be a sign of a rare systemic reaction affecting the kidneys, but it is not 'weight gain' in the traditional sense.
Calomel patch testing can be affected by certain medications, particularly those that suppress the immune system. If you are taking oral steroids like prednisone, immunosuppressants for an autoimmune condition, or even using strong steroid creams on your back, the test may give a 'false negative' result. This means the test might show you aren't allergic when you actually are. You must provide your doctor with a full list of all medications, including over-the-counter drugs and supplements, before the test begins. They will tell you which medications need to be paused and for how long to ensure the test is accurate.
Calomel is a chemical name (mercurous chloride) and is not a branded pharmaceutical product in the traditional sense. It is available as a standardized allergenic extract produced by various specialized laboratory companies for use by medical professionals. You cannot buy Calomel at a retail pharmacy, and it does not come in 'brand name' or 'generic' pill forms for consumer use. If you are being tested for a mercury allergy, the clinic will provide the necessary extract. Its use is strictly regulated due to the safety concerns surrounding mercury-containing compounds.